Find uplifting stories about heroes, innovations, and solutions
11 results for "abbvie"
When AbbVie's Week of Possibilities arrived, 17,000 employees across six continents chose to spend their work hours building homes, teaching kids science, and cleaning beaches. The pharmaceutical company's annual volunteer event turned classrooms into STEM labs and construction sites into new beginnings for families in need.
Pharmaceutical giant AbbVie is investing $1.4 billion to build a massive manufacturing campus in Durham, North Carolina, creating 734 permanent jobs and 2,000 construction positions. The project marks the largest private investment in Durham's history and puts the city on the map as a global life sciences leader.
Cancer survivor Jameson Taillon struck out 10 batters Sunday, triggering donations through a new MLB-wide partnership that turns every strikeout into cancer research funding. AbbVie's program will donate up to $1 million this season, with each Wrigley Field strikeout worth $241—representing the number of people diagnosed with cancer every hour.
One of the pharmaceutical industry's biggest players is planting roots in Durham with a $1.4 billion campus that will create over 730 jobs and produce life-saving medicines. It's the largest private investment in Durham's history and positions North Carolina as home to eight of the world's ten biggest drug makers.
A San Diego biotech company has started its first clinical trial of a groundbreaking treatment that tricks cancer cells into destroying themselves. The molecular glue technology has already attracted nearly $5 billion in deals from major pharmaceutical companies.
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
Johnson & Johnson just won approval for the first daily pill that matches the power of injectable psoriasis treatments. The breakthrough could help millions who avoid shots and reshape how we treat this painful skin condition.
From Star Trek legends to reality TV favorites, celebrities nationwide are rallying 60,000 people for PanCAN PurpleStride on April 25, aiming to raise $17 million for pancreatic cancer research and patient support. Their personal connections to the disease are turning grief into action and hope into funding for lifesaving breakthroughs.
Hundreds of women with hard-to-treat ovarian cancer will now receive a groundbreaking new therapy that extends life while dramatically reducing the debilitating side effects of traditional chemotherapy. The approval marks the first new ovarian cancer treatment on the NHS in two decades.
Hundreds of women with chemotherapy-resistant ovarian cancer in England now have access to a groundbreaking treatment that extends life and shrinks tumors. It's the first new option approved for this hard-to-treat cancer in two decades.
The U.S. government just named 15 more medications, including treatments for HIV, arthritis, and diabetes, that will see lower prices through Medicare negotiations starting in 2028. The move is expected to save billions while making essential medications more affordable for seniors and people with disabilities.